Paul Kim, Simplify and Victoria Wolodzko, Susan G. Komen discuss supporting Breast Cancer research with ETFs on ETF TV
ETF TV news #94 Paul Kim, CEO & Cofounder, Simplify, Victoria Wolodzko, Senior Vice President, Mission at Susan G. Komen the new actively managed Simplify Health Care ETF ticker PINK which will donate the profits – to the Susan G. Komen® organization with Margareta Hricova and Deborah Fuhr on ETF TV
Listen to ETF tv Podcasts on Apple on Spotify
Last week globally there were 15 new listings from 15 issuers and there were 32 new cross-listings.
Issuers included: BNP Paribas Easy, Bosera Asset Management, China Southern Fund Management, China Universal Asset Management, First Trust, Gea Sphere Advisors, Hwabao WP Fund, IPA Securities Investment Fund Management Company, iShares, KB Asset Management, Midas Asset Management, Mirae Asset Global ETFs, NH-Amundi Management, Samsung Asset Management, Yinhua Fund Management
ETF TV your insight into the world of exchange-traded funds, issuers and investment. Watch prior episodes at www.ETFtv.net.
ETF TV News is sponsored by Syntax Advisors https://www.syntaxadvisors.com/. Syntax Advisors offers a family of Syntax Stratified ETFs that aim to deliver a diversified return by providing investors with rules-based exposure to business risks.
MarketData: ETFGI, video production: Nuru Rimington-Mkali, the transcript and podcast: Mathilde Laessoe MP4: https://we.tl/t-nsGNZO7GIs
Please email Press Releases to press@ETFtv.net
Originally Posted on October 19, 2021 – Paul Kim, Simplify and Victoria Wolodzko, Susan G. Komen discuss supporting Breast Cancer research with ETFs on ETF TV
Disclaimer: ETF TV is a news update and is intended for informational purposes only. ETF TV does not provide investment advice nor recommend products.
Disclosure: ETF TV
Lyxor Asset Management S.A.S. (“Lyxor S.A.S.”) is a French investment management company authorized by the Autorité des Marchés Financiers and registered as a commodity trading advisor and commodity pool operator with the CFTC.
The information in this material is for illustration and discussion purposes only. It is not intended to be, nor should it be construed or used as, investment, tax or legal advice, a recommendation or opinion regarding the appropriateness or suitability of any investment or strategy, or an offer to sell, or a solicitation of an offer to buy, an interest in any security. Any decision to invest in a product should be made only after reading the offering document for that product, conducting such investigations as the prospective investor deems necessary after consulting with the prospective investor’s own independent investment, legal, accounting and tax advisors in order to make an informed determination of the suitability and consequences of an investment in such product. Any recommendation or opinion regarding an investment in a product managed by Lyxor S.A.S. or one of its affiliates, as opposed to another product with a similar investment program, is subject to potential conflicts of interest.
The information displayed in this document may change from time to time without notice. Certain information presented herein has been obtained from other sources believed to be reliable. Such information has not been verified for purposes of this material and no representation or warranty, express or implied, is made as to the fairness, accuracy, completeness or correctness of such information, nor does Lyxor S.A.S. accept any liability arising from its use. Any opinions expressed herein are statements of our judgment on this date and are subject to change without notice. The information contained herein is strictly confidential and may not be reproduced, in whole or in part, nor may its contents be disclosed to any other person (other than the recipient’s confidential advisers) under any circumstances without the prior written consent of Lyxor S.A.S.
Securities in certain funds mentioned herein which are managed by Lyxor S.A.S. are offered and sold to U.S. investors through SG Americas Securities, LLC (“SGAS”), an affiliate of Lyxor S.A.S. and Lyxor Inc. and a member of the U.S. Financial Regulatory Authority, the U.S. Securities Investor Protection Corporation and the New York Stock Exchange. Lyxor S.A.S. may pay a placement fee to, and provide compensation for expenses to SGAS in connection with its services provided in connection with such funds.
Disclosure: Interactive Brokers
Information posted on IBKR Campus that is provided by third-parties does NOT constitute a recommendation that you should contract for the services of that third party. Third-party participants who contribute to IBKR Campus are independent of Interactive Brokers and Interactive Brokers does not make any representations or warranties concerning the services offered, their past or future performance, or the accuracy of the information provided by the third party. Past performance is no guarantee of future results.
This material is from ETF TV and is being posted with its permission. The views expressed in this material are solely those of the author and/or ETF TV and Interactive Brokers is not endorsing or recommending any investment or trading discussed in the material. This material is not and should not be construed as an offer to buy or sell any security. It should not be construed as research or investment advice or a recommendation to buy, sell or hold any security or commodity. This material does not and is not intended to take into account the particular financial conditions, investment objectives or requirements of individual customers. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.